Jan 25, 2022
Without information on the potential return on investment for women's health research, stakeholders lack a basis for altering research investments to improve knowledge of women's health. In this report, the authors examine the societal cost impact of increasing research funding in rheumatoid arthritis and find that investing in women's health research yields benefits beyond investing in general research.
Does not include Appendixes.
|PDF file||4.7 MB|
|PDF file||0.5 MB|
Women's health has suffered from insufficient research addressing women. The research community has not widely embraced the value of this research, and the impact of limited knowledge about women's health relative to men's is far-reaching. Without information on the potential return on investment for women's health research, research funders, policymakers, and business leaders lack a basis for altering research investments to improve knowledge of women's health.
As part of an initiative of the Women's Health Access Matters (WHAM) nonprofit foundation, RAND Corporation researchers examined the impact of increasing funding for women's health research on rheumatoid arthritis (RA). RA was chosen partly because of its higher prevalence in women than men, with some symptom profiles differing by sex. In this report, the authors present the results of microsimulation models used to explore the potential for enhanced investment in women's health research, in terms of the economic well-being of women and for the U.S. population.